Status:
ACTIVE_NOT_RECRUITING
Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection
Lead Sponsor:
Verici Dx
Conditions:
Kidney Transplant Rejection
Eligibility:
All Genders
18-80 years
Brief Summary
Global, non-randomized, observational study for the validation of Verici Dx genomic tests to predict risk of kidney clinical and subclinical acute rejection, and chronic allograft damage or interstiti...
Detailed Description
The study is correlative and observational and will involve collecting clinical and pathological data along with blood, biopsy tissue and urine during standard routine scheduled medical visits for tra...
Eligibility Criteria
Inclusion
- Individual Recipients of living or deceased donor kidney transplant
- Age: ≥ 18 ≤ 80
- The subject must be able to comprehend and sign an approved informed consent form
Exclusion
- Recipients of multiple organ transplant, except kidney-pancreas multiple transplant
- Subjects who are currently participating in a therapeutic clinical trial for transplant rejection
- HIV or Hepatitis C positive patients
- Persons who are known to be pregnant
Key Trial Info
Start Date :
March 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT04727788
Start Date
March 21 2021
End Date
December 31 2025
Last Update
November 20 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612
2
Northwestern University
Evanston, Illinois, United States, 60611
3
University of Maryland
Baltimore, Maryland, United States, 21201
4
Henry Ford
Detroit, Michigan, United States, 48202